Covid-19 Research

Mini Review

Hypothyroidism Revisited: Defining the Subgroups on Optimal Thyroxine Replacement Who Have Persisting Symptoms

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

View DOI Submit Manuscript

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access
Article Type Mini Review
Subject Medicine Group
OCLC JBRES Record
Welborn TA*
Issue: Volume5-Issue9
Pages: 1127-1131
Received: 2024-09-10
Accepted: 2024-09-20
Published: 2024-09-20

Abstract

Hypothyroid patients on optimal replacement but with persisting symptoms continue to be a challenge for their treating physicians. This commentary is based on a substantial clinical experience with this subpopulation.

With the focus on laboratory tests to achieve a diagnosis, aspects of the traditional clinical examination have been overlooked. In particular the routine testing of tendon reflexes has lapsed. A delay in the relaxation phase of tendon reflexes (hypothyroid hyporeflexia), once known as a positive Woltman’s sign, has long been the hallmark sign of overt hypothyroidism. The majority will do well when treated with appropriate thyroxine replacement.

This sign is also positive in those patients on thyroxine (T4) with normal T4 and Thyrotropin (TSH) levels if they have symptomatic intracellular Triiodothyronine (T3) deficiency. These patients will respond promptly to combination therapy (T4+T3). This subgroup accounts for more than half of the thyroxine-dissatisfied population. They should be described as having T3-hypothyroidism.

The remaining symptomatic patients with normal reflexes have unrelated conditions. A small clearly defined subgroup with autoimmune symptoms and very high anti-Thyroperoxidase (anti-TPO) antibodies (>10 times the upper limit of normal) will respond to total thyroidectomy with a marked improvement that is maintained for 3-5 years. They can be categorised as having TPO-toxic hypothyroidism.

Many patients can have persistent symptoms because of psycho-social issues and the burden of having a chronic disease. They have in-denial-hypothyroidism. There are very rare cases of thyroxine allergy.

This nomenclature should assist physicians in their diagnosis and management of the several subgroups of patients on thyroxine with persistent symptoms.

FullText HTML FullText PDF DOI: 10.37871/jbres2000 Crossmark

Certificate of Publication

Certificate of Publication

Copyright

© 2024 Welborn TA. Distributed under Creative Commons CC-BY 4.0 Creative CommonsAttribution

How to cite this article

Welborn TA. Hypothyroidism Revisited: Defi ning the Subgroups on Optimal Thyroxine Replacement Who Have Persisting Symptoms. J Biomed Res Environ Sci. 2024 Sept 20; 5(9): 1127-1131. doi: 10.37871/jbres2000, Article ID: JBRES2000, Available at: https://www.jelsciences.com/articles/jbres2000.pdf

Subject area(s)

Clinical Endocrinology

References

  1. Wiersinga WM, Duntas L, Fadeyev V, Nygaard B, Vanderpump MP. 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism. Eur Thyroid J. 2012 Jul;1(2):55-71. doi: 10.1159/000339444. Epub 2012 Jun 13. PMID: 24782999; PMCID: PMC3821467.
  2. Peterson SJ, Cappola AR, Castro MR, Dayan CM, Farwell AP, Hennessey JV, Kopp PA, Ross DS, Samuels MH, Sawka AM, Taylor PN, Jonklaas J, Bianco AC. An Online Survey of Hypothyroid Patients Demonstrates Prominent Dissatisfaction. Thyroid. 2018 Jun;28(6):707-721. doi: 10.1089/thy.2017.0681. Epub 2018 Apr 5. PMID: 29620972; PMCID: PMC6916129.
  3. Biondi B, Celi FS, McAninch EA. Critical Approach to Hypothyroid Patients With Persistent Symptoms. J Clin Endocrinol Metab. 2023 Sep 18;108(10):2708-2716. doi: 10.1210/clinem/dgad224. Erratum in: J Clin Endocrinol Metab. 2024 Jan 18;109(2):e877. doi: 10.1210/clinem/dgad678. PMID: 37071856; PMCID: PMC10686697.
  4. Jonklaas J, Tefera E, Shara N. Short-Term Time Trends in Prescribing Therapy for Hypothyroidism: Results of a Survey of American Thyroid Association Members. Front Endocrinol (Lausanne). 2019 Jan 30;10:31. doi: 10.3389/fendo.2019.00031. PMID: 30761091; PMCID: PMC6363658.
  5. Taylor S, Kapur M, Adie R. Combined thyroxine and triiodothyronine for thyroid replacement therapy. Br Med J. 1970 May 2;2(5704):270-1. doi: 10.1136/bmj.2.5704.270. PMID: 5420176; PMCID: PMC1700438.
  6. Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med. 1999 Feb 11;340(6):424-9. doi: 10.1056/NEJM199902113400603. PMID: 9971866.
  7. Millan-Alanis JM, González-González JG, Flores-Rodríguez A, Singh Ospina N, Maraka S, Moreno-Peña PJ, Brito JP, González-Velázquez C, Rodríguez-Gutiérrez R. Benefits and Harms of Levothyroxine/L-Triiodothyronine Versus Levothyroxine Monotherapy for Adult Patients with Hypothyroidism: Systematic Review and Meta-Analysis. Thyroid. 2021 Nov;31(11):1613-1625. doi: 10.1089/thy.2021.0270. Epub 2021 Sep 28. PMID: 34340589; PMCID: PMC8917901.
  8. Jonklaas J, Bianco AC, Cappola AR, Celi FS, Fliers E, Heuer H, McAninch EA, Moeller LC, Nygaard B, Sawka AM, Watt T, Dayan CM. Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document. Thyroid. 2021 Feb;31(2):156-182. doi: 10.1089/thy.2020.0720. PMID: 33276704; PMCID: PMC8035928.
  9. Amato-Stratman M. Radioiodine therapy for hyperthyroidism. N Engl J Med. 2011;364:1978-1979.
  10. Ettleson MD, Bianco AC. Individualized Therapy for Hypothyroidism: Is T4 Enough for Everyone? J Clin Endocrinol Metab. 2020 Sep 1;105(9):e3090–104. doi: 10.1210/clinem/dgaa430. PMID: 32614450; PMCID: PMC7382053.    
  11. Welborn TA. More trials for the unhappy hypothyroid patient on thyroxine: a clinician's perspective. Trends Endocrinol Metab. 2022 Aug;33(8):536-538. doi: 10.1016/j.tem.2022.04.010. Epub 2022 May 23. PMID: 35618561.
  12. Sosnay PR, Kim S. Hypothyroid-induced hyporeflexia. N Engl Med. 2006;354:e27. doi: 10.1056/NEJMicm050622.
  13. Iwasaki Y, Fukaya K. Woltman's Sign of Hypothyroidism. N Engl J Med. 2018 Oct 4;379(14):e23. doi: 10.1056/NEJMicm1713796. PMID: 30281985.
  14. Welborn TA. Endocrinologists- Do you remember Woltman’s sign? J Biomed Res Environ Sci. 2024;5(6):580-583. doi: 10.37871/jbres1757.
  15. Galton VA. The ups and downs of the thyroxine pro-hormone hypothesis. Mol Cell Endocrinol. 2017 Dec 15;458:105-111. doi: 10.1016/j.mce.2017.01.029. Epub 2017 Jan 24. PMID: 28130114.
  16. Galton VA, Hernandez A. Thyroid Hormone Metabolism: A Historical Perspective. Thyroid. 2023 Jan;33(1):24-31. doi: 10.1089/thy.2022.0161. Epub 2022 Aug 1. PMID: 35699066; PMCID: PMC9885541.
  17. Panicker V, Saravanan P, Vaidya B, Evans J, Hattersley AT, Frayling TM, Dayan CM. Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients. J Clin Endocrinol Metab. 2009 May;94(5):1623-9. doi: 10.1210/jc.2008-1301. Epub 2009 Feb 3. PMID: 19190113.
  18. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA, Woeber KA; American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012 Nov-Dec;18(6):988-1028. doi: 10.4158/EP12280.GL. Erratum in: Endocr Pract. 2013 Jan-Feb;19(1):175. PMID: 23246686.
  19. Welborn TA, Dhaliwal SS. Hypothyroidism: A small clinical trial will quickly resolve the combination therapy controversy. Int J Clin Biostat Biom. 2022;8:49-50. doi: 10.23937/2469-5831/1510049.
  20. Ott J, Promberger R, Kober F, Neuhold N, Tea M, Huber JC, Hermann M. Hashimoto's thyroiditis affects symptom load and quality of life unrelated to hypothyroidism: a prospective case-control study in women undergoing thyroidectomy for benign goiter. Thyroid. 2011 Feb;21(2):161-7. doi: 10.1089/thy.2010.0191. Epub 2010 Dec 27. Erratum in: Thyroid. 2011 Apr;21(4):467. PMID: 21186954.
  21. Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R, Dayan CM. Psychological well-being in patients on 'adequate' doses of l-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf). 2002 Nov;57(5):577-85. doi: 10.1046/j.1365-2265.2002.01654.x. PMID: 12390330.
  22. Guldvog I, Reitsma LC, Johnsen L, Lauzike A, Gibbs C, Carlsen E, Lende TH, Narvestad JK, Omdal R, Kvaløy JT, Hoff G, Bernklev T, Søiland H. Thyroidectomy Versus Medical Management for Euthyroid Patients With Hashimoto Disease and Persisting Symptoms: A Randomized Trial. Ann Intern Med. 2019 Apr 2;170(7):453-464. doi: 10.7326/M18-0284. Epub 2019 Mar 12. PMID: 30856652.
  23. Hoff G, Bernklev T, Johnsen L, Reitsma L, Sina D, Lauzike A, Gibbs C, Carlsen E, Lende TH, Narvestad JK, Kildahl R, Omdal R, Kvaløy JT, Søiland H. Thyroidectomy for Euthyroid Patients With Hashimoto Disease and Persisting Symptoms. Ann Intern Med. 2024 Jan;177(1):101-103. doi: 10.7326/M23-1593. Epub 2023 Nov 28. PMID: 38011703.
  24. Attanasio R, Žarković M, Papini E, Nagy EV, Negro R, Perros P, Akarsu E, Alevizaki M, Ayvaz G, Bednarczuk T, Beleslin BN, Berta E, Bodor M, Borissova AM, Boyanov M, Buffet C, Burlacu MC, Ćirić J, Díez JJ, Dobnig H, Fadeyev V, Field BCT, Fliers E, Führer-Sakel D, Galofré JC, Hakala T, Jiskra J, Kopp PA, Krebs M, Kršek M, Kužma M, Lantz M, Lazúrová I, Leenhardt L, Luchytskiy V, Marques Puga F, McGowan A, Metso S, Moran C, Morgunova T, Niculescu DA, Perić B, Planck T, Poiana C, Robenshtok E, Rosselet PO, Ruchala M, Ryom Riis K, Shepelkevich A, Tronko MD, Unuane D, Vardarli I, Visser WE, Vryonidou A, Younes YR, Hegedüs L. Patients' Persistent Symptoms, Clinician Demographics, and Geo-Economic Factors Are Associated with Choice of Therapy for Hypothyroidism by European Thyroid Specialists: The "THESIS" Collaboration. Thyroid. 2024 Apr;34(4):429-441. doi: 10.1089/thy.2023.0580. Epub 2024 Mar 22. PMID: 38368541.
  25. Chamorro-Pareja N, Carrillo-Martin I, Haehn DA, Westphal SA, Park MA, Bernet VJ, Gonzalez-Estrada A. Self-Reported Allergy to Thyroid Replacement Therapy: A Multicenter Retrospective Chart Review. Endocr Pract. 2020 Jul;26(7):761-767. doi: 10.4158/EP-2019-0488. Epub 2020 Nov 24. PMID: 33471645.
  26. Gansert E, Garzon-Siatoya W, Morgenstein-Kaplan D, Gonzalez-Estrado A. A tale of two patients with hypersensitivity reactions to levothyroxine. Quart J Med. 2022;115:327-328. doi: 10.1093/qjmed/hcac029.
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership